Lamotrigine in patients with bipolar disorder and cocaine dependence

Journal of Clinical Psychiatry

Volumn 64, Issue 2, 2003, Pages 197-201

  Brown, E Sherwood ^a   Nejtek, Vicki A ^a   Perantie, Dana C ^a   Orsulak, Paul J ^a,b   Bobadilla, Leonardo ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; CLONAZEPAM; DOXEPIN; GABAPENTIN; HYDROXYZINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRAZODONE; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COCAINE CRAVING QUESTIONNAIRE; COCAINE DEPENDENCE; DIARRHEA; DISEASE EXACERBATION; DRUG TOLERABILITY; EVALUATION; FATIGUE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INTERVIEW; LIBIDO DISORDER; MALE; MANIA; MONOTHERAPY; MOOD; NAUSEA; OBSERVATION; OPEN STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; RATING SCALE; SCORING SYSTEM; TITRIMETRY; TREMOR; URINALYSIS; VERTIGO; WITHDRAWAL SYNDROME; YOUNG MANIA RATING SCALE;

EID: 0037325339     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0213     Document Type: Article

References (18)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990;264:2511-2518
2. Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17-31
3. Brown ES, Suppes T, Adinoff B, et al. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affect Disord 2001;65:105-115
4. Geller B, Cooper TB, Kaisun MA, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-178
5. Brady KT, Sonne SC, Anton R, et al. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 1995;56:118-121
6. Brady KT. Sonne SC, Dansky BS, et al. Carbamazepine in cocaine-dependent individuals with affective disorder. Presented at the 60th annual meeting of the College on Problems of Drug Dependence; June 12-17, 1998; Scottsdale, Ariz
7. Calabrese JR, Shelton MD, Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001;62(suppl 14): 34-41
8. Calabrese JR, Suppes T, Bowden CL, et al, for the Lamictal 614 Study Group. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-850
9. Calabrese JR, Bowden CL, Sachs GS, et al, for the Lamictal 602 Study Group. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
10. Winther LC, Saleem R, McCance-Katz EF, et al. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. Am J Drug Alcohol Abuse 2000;26:47-59
11. Margolin A, Avants SK, DePhilippis D, et al. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse 1998;24:85-101
12. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
14. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435
15. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
16. Tiffany ST, Singleton E, Haertzen CA, et al. The development of a cocaine craving questionnaire. Drug Alcohol Depend 1993;34:19-28
17. Xie X, Hagan RM. Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 1998;38:119-130
18. Wang SJ, Sihra TS, Gean PW. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. NeuroReport 2001;12:2255-2258